cis-platinum
Showing 1 - 4 of 4
Envafolimab Combined With Endostar and Concurrent
Not yet recruiting
- Cervical Cancer
- cis-platinum
- +3 more
- (no location specified)
May 19, 2023
Advanced NSCLC Trial in Jilin (pemetrexed, Cetuximab, cis-platinum)
Not yet recruiting
- Advanced Non-Small Cell Lung Cancer
- pemetrexed
- +5 more
-
Jilin, Changchun, ChinaJilin Province Cancer Hospital
Aug 15, 2022
NSCLC Stage III Trial in China (Erlotinib, cis-platinum, Vinorelbine)
Unknown status
- Non-small Cell Lung Cancer Stage III
- Erlotinib
- +2 more
-
Tianjin, Tianjin, China
- +14 more
Oct 19, 2016
NSCLC Trial in Urumqi (Pemetrexed, Docetaxel, rh-Endostatin)
Unknown status
- Non-small Cell Lung Cancer
- Pemetrexed
- +3 more
-
Urumqi, Xinjiang, ChinaCancer Hospital of Xinjiang Medical University
Nov 26, 2013